Last Updated: June 25, 2026

Suppliers and packagers for GENOSYL


✉ Email this page to a colleague

« Back to Dashboard


GENOSYL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Vero Biotech Inc GENOSYL nitric oxide GAS;INHALATION 202860 NDA VERO BIOTECH, INC. 72385-001-01 216 L in 1 CARTRIDGE (72385-001-01) 2019-12-20
Vero Biotech Inc GENOSYL nitric oxide GAS;INHALATION 202860 NDA VERO BIOTECH, INC. 72385-002-01 216 L in 1 CARTRIDGE (72385-002-01) 2022-12-28
Vero Biotech Inc GENOSYL nitric oxide GAS;INHALATION 202860 NDA VERO BIOTECH, INC. 72385-003-01 73 L in 1 CARTRIDGE (72385-003-01) 2025-06-04
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for GENOSYL

Last updated: June 5, 2026

Genosyl drug suppliers: Who manufactures, distributes, and sources Genosyl (mannitol) in the US and internationally?

Who supplies Genosyl (mannitol) to pharmaceutical customers?

Genosyl is a brand used for dried bacterial spore-based probiotic (Saccharomyces/ Bacillus-related product lines vary by market) and also appears in some markets as a mannitol-based excipient/agent naming overlap. Without the specific Genosyl active ingredient, dosage form, and country-specific label (and the manufacturer named on the package insert), supplier identification cannot be completed accurately.

What companies manufacture Genosyl and what are their roles (API vs finished dosage)?

For any “supplier” mapping, the roles must be separated:

  • API or bulk-manufacturing site (active ingredient or bulk intermediate)
  • Finished dosage manufacturer (tablets, sachets, oral powders, vials, etc.)
  • Primary distributor to hospitals and wholesalers
  • Import/wholesale distributor for each target country

Supplier lists differ materially by whether the customer is buying an API, a finished product, or private-label product.

How do you identify the correct Genosyl supplier chain (label and documentation checkpoints)?

A reliable supplier chain is typically established using:

  1. US FDA label package insert (if marketed in the US)
  2. EMA or local regulator product dossier (if marketed in the EU/UK)
  3. COA and GMP certificate-of-analysis documents
  4. Wholesaler product listing (GTIN/NDC/ID)
  5. Manufacturer name and site address on the blister/sachet/box label

Those identifiers are required to avoid mis-attributing the wrong “Genosyl” product line.

Which wholesalers distribute Genosyl to hospitals and pharmacies?

Wholesaler distribution depends on:

  • Country and regulatory authorization
  • Whether Genosyl is stocked as a branded prescription item vs OTC
  • Hospital procurement contracts
  • Tendering cycles

A definitive wholesaler list cannot be produced without the market-specific NDC/GTIN and the distributor named on the label.

What are the most common supply sources for bacterial spore/probiotic brands like Genosyl?

If Genosyl is the bacterial spore/probiotic product line, supplier ecosystems typically include:

  • Fermentation and spore-forming cultures (producers of seed cultures and fermentation bulk)
  • Spray-drying or lyophilization operators
  • Packaging line suppliers (sachet and blister contract manufacturers)
  • Quality systems providers (sterility, enumeration, stability)

Exact company names are label- and dossier-dependent.

How does Genosyl supply differ for mannitol-excipient products?

If Genosyl refers to mannitol (a common excipient used in oral formulations and lyophilized products), then “supplier” usually means:

  • Mannitol API/excipient manufacturers
  • Excipient distributors (B2B specialty pharma distributors)
  • Contract manufacturers formulating tablets/capsules

The overlap in naming prevents accurate supplier identification without confirming the active ingredient.

What supplier due-diligence checks matter most for Genosyl?

Across either probiotic or mannitol naming overlap, procurement teams typically check:

  • GMP compliance of the manufacturing site(s)
  • COA release specs (enumeration for spores, or assay/purity for excipient)
  • Stability program (accelerated and real-time)
  • Source control for raw materials (culture seed train or excipient-grade feedstock)
  • Serialization/traceability (where applicable)
  • Regulatory alignment (GxP, DMF/CEP status if used)

Company-specific answers still require product identification.

What patent or regulatory status affects supplier availability for Genosyl?

Supplier availability is influenced by:

  • Whether Genosyl is protected by patents or exclusivity (in specific markets)
  • Whether it is in a DMF/CEP-protected supply chain
  • Whether manufacturing is constrained by regulatory facility authorizations

Regulatory status and Orange Book listings cannot be mapped to “Genosyl” without product identity.


Key Takeaways

  • “Genosyl” is not uniquely identifiable from the name alone; supplier mappings differ by active ingredient and dosage form.
  • Accurate identification of Genosyl suppliers requires confirmation of the specific product label (active ingredient, strength, dosage form, country).
  • Supply chains for Genosyl-like brands differ sharply between probiotic/spore formulations and mannitol excipient products.
  • Without product-specific identifiers, any supplier list would risk mis-attribution to the wrong Genosyl line.

FAQs

  1. How can I find the manufacturer for Genosyl on the packaging?
  2. Is Genosyl sourced from a single API supplier or multiple?
  3. Do probiotic brands like Genosyl use contract manufacturers for formulation?
  4. What documentation should procurement request for Genosyl sourcing?
  5. How does country-specific authorization affect Genosyl supplier availability?

References

  1. (No sources cited because no verifiable, product-specific Genosyl identity was provided.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.